Full Press Release Details
CINCINNATI --(BUSINESS WIRE)--Sep. 23, 2025-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025 . The Company will host a conference call the following morning, Thursday, October 23, 2025 , at 9:00 a.m. ET to discuss these results.
To participate in the conference call, interested parties must register in advance by clicking on this link . While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.
To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com . The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio , Medpace employs approximately 6,000 people across 44 countries as of June 30, 2025 .
View source version on businesswire.com : https://www.businesswire.com/news/home/20250923190388/en/
Investor Contact: Lauren Morris 513.579.9911 x11994 l.morris@medpace.com
Media Contact: Michael Maley 513.579.9911 x12831 m.maley@medpace.com
Source: Medpace Holdings, Inc.